Evaluation of Postural Control in Children Using Tetra Axial Posturography

NCT ID: NCT00922558

Last Updated: 2010-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

480 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tetra-ataxiametric posturography is based on the measurement and computerized elaboration of electronic signals emitted by four footplates, one for each heel and toe, respectively. These are sensitive to vertical pressure produced by a subject standing straight but in various positions (feet parallel, in tandem, eyes closed, on pads, etc.). The method yields additional parameters not obtained by the traditional monoplate stabilometers, namely, weight-distribution patterns and correlation among six combinations of paired outputs from the two heels, two toes, heel/toe of each foot, and the two diagonals (tetra-ataxiametric synchronizations). Comparing age-matched learning disabled, mentally retarded, autistic, and hearing impaired (with and without labyrinthine hypofunction) with normal children, significant and clinically meaningful differences were detected between the Tetra-ataxiametric measures of stability, interaction between Fourier Spectral Power Ranges of body sway, weight distributions, and synchronizations of toe parts. The same parameters correlated significantly with cognitive school readiness in normal populations. While the stability and spectral quotients show significant developmental changes, weight distribution and toe synchronisations are stable from 5 years onwards. The method is suitable for young subjects and attractive to children who may ordinarily be reluctant to cooperate, such as the autistic ones. The equipment is portable and tests can be conveniently carried out in a child's familiar educational setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recently a new pediatric software was introduced for the TETRAX device. The goal of the present study is to create normative data for children starting at preschool age using the newly developed software. Four hundred and 80 children between the ages of 5 and 12 years old will be examined following informed consent from the children and their legal guardian.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Normal Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

normal children

Normal children ages 5-12 years.

Group Type NO_INTERVENTION

Evaluation of postural control

Intervention Type OTHER

Children will be measured once using a Tetra-aximetric posturography method

postural control

Group Type EXPERIMENTAL

Evaluation of postural control

Intervention Type OTHER

Children will be measured once using a Tetra-aximetric posturography method

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluation of postural control

Children will be measured once using a Tetra-aximetric posturography method

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 5-12 years
* healthy

Exclusion Criteria

* children with known disturbances in bone, muscle of nervous systems
* children using medications that may cause problems in balance or coordination
Minimum Eligible Age

5 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Meir Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Meir Medical Center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dan Nemet, MD

Role: PRINCIPAL_INVESTIGATOR

Pediatrics, Meir Medical Center, Sackler School of Medicine, Tel Aviv University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Reoven Cohen-Raz

Jerusalem, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Reoven Cohen-Raz, Phd

Role: CONTACT

972-52-5402771

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Reoven Cohen-Raz, Phd

Role: primary

972-52-5402771

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MeirMc068-09CTIL

Identifier Type: -

Identifier Source: org_study_id